About Kaia Health
Kaia Health is a digital therapeutics company specializing in musculoskeletal (MSK) pain management and respiratory care through its Kaia MSK and Kaia Breathe programs. The company delivers evidence-based, app-based therapeutic interventions that replicate best-in-class multimodal treatment traditionally provided in clinical settings. All programs are developed by in-house Doctors of Physical Therapy and regularly updated to meet the latest national guidelines. Kaia's approach eliminates barriers to access by providing care on-demand without requiring appointments or devices. The company has demonstrated clinical efficacy across 11 clinical trials and proven cost-effectiveness with regular claims studies showing at least 3x ROI for employers and health plans. Kaia Health serves over 2,500 employers and health plans globally and has been integrated into some of the world's largest healthcare organizations. The company was acquired by Sword Health, expanding its reach in the digital MSK care market. Kaia's solutions are designed to deliver strong clinical outcomes while reducing healthcare costs, making evidence-based care accessible at scale.
Clinical Focus
Medical conditions and clinical areas addressed by Kaia Health.
Who It Serves
Milestones & Awards
Recent Milestones
Kaia Health acquired by Sword Health
Key Partnerships
Social & Media
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 46 →Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
Arkray
ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Cala Health
Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.




